DK175504B1 - Farmaceutisk præparat indeholdende 3alfa-hydroxy-5beta-pregnan-20-on og fremstilling deraf - Google Patents
Farmaceutisk præparat indeholdende 3alfa-hydroxy-5beta-pregnan-20-on og fremstilling deraf Download PDFInfo
- Publication number
- DK175504B1 DK175504B1 DK198700621A DK62187A DK175504B1 DK 175504 B1 DK175504 B1 DK 175504B1 DK 198700621 A DK198700621 A DK 198700621A DK 62187 A DK62187 A DK 62187A DK 175504 B1 DK175504 B1 DK 175504B1
- Authority
- DK
- Denmark
- Prior art keywords
- oil
- pregnanolone
- amount
- water
- final preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Anesthesiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8600632A SE8600632D0 (sv) | 1986-02-13 | 1986-02-13 | Novel pharmaceutical composition |
SE8600632 | 1986-02-13 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK62187D0 DK62187D0 (da) | 1987-02-06 |
DK62187A DK62187A (da) | 1987-08-14 |
DK175504B1 true DK175504B1 (da) | 2004-11-15 |
Family
ID=20363448
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK198700621A DK175504B1 (da) | 1986-02-13 | 1987-02-06 | Farmaceutisk præparat indeholdende 3alfa-hydroxy-5beta-pregnan-20-on og fremstilling deraf |
Country Status (14)
Country | Link |
---|---|
US (1) | US5028600A (sv) |
EP (1) | EP0233849B1 (sv) |
JP (1) | JPH0788305B2 (sv) |
AT (1) | ATE64526T1 (sv) |
CA (1) | CA1301651C (sv) |
DE (1) | DE3770830D1 (sv) |
DK (1) | DK175504B1 (sv) |
ES (1) | ES2037742T3 (sv) |
FI (1) | FI88676C (sv) |
GR (1) | GR3002299T3 (sv) |
HK (1) | HK83293A (sv) |
NO (1) | NO175040B (sv) |
SE (1) | SE8600632D0 (sv) |
SG (1) | SG102892G (sv) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9302295D0 (sv) * | 1993-07-02 | 1993-07-02 | Kabi Pharmacia Ab | New pharmaceutical composition |
US5616330A (en) * | 1994-07-19 | 1997-04-01 | Hemagen/Pfc | Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same |
WO1999007381A1 (en) * | 1997-08-11 | 1999-02-18 | Weider Nutrition International, Inc. | Compositions and treatments to reduce side effects of administration of androgenic testosterone precursors |
US20020155161A1 (en) * | 2000-12-29 | 2002-10-24 | Deckelbaum Richard J. | Use of IV emulsions with different triglyceride composition, particle size and apolipoprotein E for targeted tissue delivery of hydrophobic compounds |
EP3513813A1 (en) * | 2002-07-02 | 2019-07-24 | Astrazeneca | Ciclesonide-containing sterile aqueous suspension |
PE20050941A1 (es) * | 2003-12-16 | 2005-11-08 | Nycomed Gmbh | Suspensiones acuosas de ciclesonida para nebulizacion |
EA200700440A1 (ru) * | 2004-09-13 | 2008-02-28 | Бхарат Сирумс Энд Вэксинс Лтд. | Композиции стабильных эмульсий для внутривенного введения, имеющие защитную эффективность |
WO2012096697A1 (en) * | 2011-01-14 | 2012-07-19 | Simpkins Cuthbert O | Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
WO2013043985A1 (en) * | 2011-09-23 | 2013-03-28 | The Regents Of The University Of California | Edible oils to enhance delivery of orally administered steroids |
SG10201606063RA (en) | 2012-01-23 | 2016-09-29 | Sage Therapeutics Inc | Neuroactive steroid formulations and methods of treating cns disorders |
WO2014028398A2 (en) | 2012-08-13 | 2014-02-20 | The Regents Of The University Of California | Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids |
IL304912A (en) | 2012-08-21 | 2023-10-01 | Sage Therapeutics Inc | Treatment methods for epilepsy and status epilepticus |
EP2925327B1 (en) | 2012-11-30 | 2024-01-10 | The Regents of The University of California | Allopregnanolone for treating, reducing or mitigating symptoms of post-partum depression |
JOP20200195A1 (ar) | 2014-09-08 | 2017-06-16 | Sage Therapeutics Inc | سترويدات وتركيبات نشطة عصبياً، واستخداماتها |
WO2017156103A1 (en) | 2016-03-08 | 2017-09-14 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
JP2022514991A (ja) * | 2018-12-10 | 2022-02-16 | ハロー・サイエンス・エル・エル・シー | 安定な麻酔薬製剤および関連する剤形 |
CA3151334C (en) * | 2019-08-19 | 2024-04-09 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Topical neurosteroid formulations |
CN114344309B (zh) * | 2021-12-30 | 2024-02-06 | 南京迈诺威医药科技有限公司 | 一种别孕烷醇酮衍生物自乳化制剂及其制备方法 |
US11969434B1 (en) | 2022-08-29 | 2024-04-30 | Lipocine Inc. | Oral allopregnanolone compositions and methods of use |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1215702B (de) * | 1962-07-03 | 1966-05-05 | Merck Ag E | Verfahren zur Herstellung von 1alpha-Alkylthio-3-keto-androstanen |
CA895860A (en) * | 1969-11-05 | 1972-03-21 | Kruger Gunther | PROCESS FOR THE PREPARATION OF 3.alpha.-HYDROXY-5.beta.-PREGNAN-20-ONE |
US3917830A (en) * | 1970-12-17 | 1975-11-04 | Glaxo Lab Ltd | Steroidal anaesthetic composition for intraveneous injection |
US3900561A (en) * | 1970-12-17 | 1975-08-19 | Glaxo Lab Ltd | Pharmaceutical compositions |
US4168308A (en) * | 1976-03-12 | 1979-09-18 | Apoteksvarucentralen Vitrum Ab | Composition for enhancing the administration of pharmacologically active agents |
JPS609726B2 (ja) * | 1980-05-15 | 1985-03-12 | 株式会社 ミドリ十字 | ステロイド製剤 |
JPS5716818A (en) * | 1981-04-25 | 1982-01-28 | Green Cross Corp:The | Steroid fatty emulsion |
JPS60258110A (ja) * | 1984-06-05 | 1985-12-20 | Daigo Eiyou Kagaku Kk | 静脈注射可能なプロゲステロン乳化注射液 |
-
1986
- 1986-02-13 SE SE8600632A patent/SE8600632D0/sv unknown
-
1987
- 1987-01-29 EP EP87850029A patent/EP0233849B1/en not_active Expired - Lifetime
- 1987-01-29 AT AT87850029T patent/ATE64526T1/de not_active IP Right Cessation
- 1987-01-29 DE DE8787850029T patent/DE3770830D1/de not_active Expired - Fee Related
- 1987-01-29 ES ES198787850029T patent/ES2037742T3/es not_active Expired - Lifetime
- 1987-02-06 DK DK198700621A patent/DK175504B1/da not_active IP Right Cessation
- 1987-02-12 NO NO870560A patent/NO175040B/no not_active IP Right Cessation
- 1987-02-12 JP JP62028395A patent/JPH0788305B2/ja not_active Expired - Fee Related
- 1987-02-12 FI FI870589A patent/FI88676C/sv not_active IP Right Cessation
- 1987-02-12 CA CA000529609A patent/CA1301651C/en not_active Expired - Fee Related
-
1989
- 1989-02-28 US US07/316,576 patent/US5028600A/en not_active Expired - Lifetime
-
1991
- 1991-07-11 GR GR91400996T patent/GR3002299T3/el unknown
-
1992
- 1992-10-07 SG SG1028/92A patent/SG102892G/en unknown
-
1993
- 1993-08-12 HK HK832/93A patent/HK83293A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO175040C (sv) | 1994-08-24 |
GR3002299T3 (en) | 1992-12-30 |
ATE64526T1 (de) | 1991-07-15 |
US5028600A (en) | 1991-07-02 |
FI88676B (fi) | 1993-03-15 |
FI88676C (sv) | 1993-06-28 |
DK62187A (da) | 1987-08-14 |
DE3770830D1 (de) | 1991-07-25 |
JPH0788305B2 (ja) | 1995-09-27 |
CA1301651C (en) | 1992-05-26 |
HK83293A (en) | 1993-08-20 |
FI870589A0 (fi) | 1987-02-12 |
NO175040B (no) | 1994-05-16 |
EP0233849B1 (en) | 1991-06-19 |
EP0233849A1 (en) | 1987-08-26 |
ES2037742T3 (es) | 1993-07-01 |
NO870560D0 (no) | 1987-02-12 |
FI870589A (fi) | 1987-08-14 |
NO870560L (no) | 1987-08-14 |
SE8600632D0 (sv) | 1986-02-13 |
DK62187D0 (da) | 1987-02-06 |
SG102892G (en) | 1992-12-04 |
JPS62192322A (ja) | 1987-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK175504B1 (da) | Farmaceutisk præparat indeholdende 3alfa-hydroxy-5beta-pregnan-20-on og fremstilling deraf | |
DE3853191T2 (de) | Arzneimittelträger. | |
KR100410937B1 (ko) | 프로포폴을 함유하는 혈관주사용 마취제 조성물 | |
US5651991A (en) | Drug carriers | |
AT408945B (de) | Orale pharmazeutische zubereitung | |
JPH08511245A (ja) | 薬剤搬送ビヒクルとしての固体脂肪ナノエマルジョン体 | |
EP2252267A2 (de) | Lyophilisierte nanoemulsion | |
WO2016124162A1 (zh) | 一种丙泮尼地药物组合物及其制备方法 | |
JPH02203A (ja) | 薬物担体 | |
JPS62270521A (ja) | フルルビプロフエン眼投与製剤 | |
DE69525740T2 (de) | Spezielle halofantrinhaltige Zusammensetzungen | |
US6069165A (en) | Pharmaceutical compositions containing amisulpride and their therapeutic applications | |
JPH10510267A (ja) | スフィンゴ脂質の投与に適したエマルジョン及びその使用 | |
EP4062904A1 (en) | Liquid crystalline structure-forming omega-3-fatty acid composition | |
JP3074734B2 (ja) | 分散製剤 | |
JP2930242B2 (ja) | 非経口投与用エマルジヨン | |
RU2141313C1 (ru) | Фармацевтическая эмульсия, содержащая биологически активные стероиды, и способ получения эмульсии | |
EP0418004B1 (en) | Preventive and therapeutic agent for hepatitis | |
EP0350864B1 (en) | Aqueous solution containing fat-soluble vitamin k | |
JP2022514991A (ja) | 安定な麻酔薬製剤および関連する剤形 | |
CN108653204B (zh) | 一种多烯磷脂酰胆碱注射液药物组合物及其制备方法 | |
JPH0489430A (ja) | 低血圧維持剤 | |
DE3411910A1 (de) | Galenische zubereitung | |
MXPA96004611A (es) | Base libre de halogenofantrina para el tratamiento de malaria y composiciones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed |
Country of ref document: DK |